| Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. J Armitage, L Bowman, K Wallendszus, R Bulbulia, K Rahimi, R Haynes, ... Lancet (London, England) 376 (9753), 2010 | 534 | 2010 |
| Autophagy and organelle homeostasis in cancer DR Miller, A Thorburn Developmental cell 56 (7), 906-918, 2021 | 95 | 2021 |
| The interplay of autophagy and non-apoptotic cell death pathways DR Miller, SD Cramer, A Thorburn International review of cell and molecular biology 352, 159-187, 2020 | 44 | 2020 |
| Statin derivatives as therapeutic agents for castration-resistant prostate cancer MA Ingersoll, DR Miller, O Martinez, CB Wakefield, KC Hsieh, MV Simha, ... Cancer letters 383 (1), 94-105, 2016 | 31 | 2016 |
| p66Shc regulates migration of castration-resistant prostate cancer cells MA Ingersoll, YW Chou, JS Lin, TC Yuan, DR Miller, Y Xie, Y Tu, ... Cellular signalling 46, 1-14, 2018 | 21 | 2018 |
| ErbB-2 signaling in advanced prostate cancer progression and potential therapy DR Miller, MA Ingersoll, MF Lin Endocrine-related cancer 26 (4), R195-R209, 2019 | 20 | 2019 |
| p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance DR Miller, MA Ingersoll, A Chatterjee, B Baker, S Shrishrimal, ... Free Radical Biology and Medicine 139, 24-34, 2019 | 19 | 2019 |
| Targeting treatment options for castration-resistant prostate cancer DR Miller, MA Ingersoll, BA Teply, MF Lin American Journal of Clinical and Experimental Urology 9 (1), 101, 2021 | 17 | 2021 |
| Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer DR Miller, CC Tzeng, T Farmer, ET Keller, S Caplan, YS Chen, YL Chen, ... Cancer letters 436, 96-108, 2018 | 9 | 2018 |
| Combination treatment options for castration-resistant prostate cancer DR Miller, MA Ingersoll, BA Teply, MF Lin Exon Publications, 59-79, 2021 | 8 | 2021 |
| A novel pregnene analogs: synthesis, cytotoxicity on prostate cancer of PC-3 and LNCPa-AI cells and in silico molecular docking study NA Abdul-Rida, AM Farhan, NA Al-Masoudi, BA Saeed, D Miller, MF Lin Molecular diversity 25, 661-671, 2021 | 8 | 2021 |
| Anti-androgen abiraterone acetate improves the therapeutic efficacy of statins on castration-resistant prostate cancer cells DR Miller, MA Ingersoll, Y Chou, CB Wakefield, Y Tu, FF Lin, WG Chaney, ... Journal of oncology research and therapy 3 (5), 2017 | 7 | 2017 |
| Dynamics of antioxidant heme oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression DR Miller, MA Ingersoll, YW Chou, EA Kosmacek, RE Oberley-Deegan, ... Free Radical Biology and Medicine 193, 274-291, 2022 | 3 | 2022 |
| The Role of ROS in the Progression and Treatment of Castration-Resistant Prostate Cancer DR Miller | 1 | 2019 |
| Statins Enhances Anti-Androgen Abiraterone Acetate Therapeutic Efficacy on Castration-Resistant Prostate Cancer Cells DR Miller, MA Ingersoll, Y Chou, MF Lin BP International, 2022 | | 2022 |
| p66Shc/ROS enhances the progression of androgen-sensitive towards castration-resistant prostate cancer cells D Miller, M Ingersoll, A Chatterjee, R Oberley-Deegan, MF Lin Cancer Research 79 (13_Supplement), 4285-4285, 2019 | | 2019 |
| Nabeel A. Abdul-Rida, Ali M. Farhan, Najim A. Al-Masoudi, Bahjat A. Saeed D Miller, MF Lin | | |
